NEW YORK, Feb. 28 - Orchid BioSciences on Thursday reported a 112 percent jump in fourth-quarter revenue as a significant increase in total expenses fueled a widened net loss.

For the period ended Dec. 31, Orchid reported total revenue of $11.4 million compared with $5.4 million one year ago, an increase the company pinned on increased sales of its SNPware and MegaSNPatron tools, and from its DNA identity-testing services and license fees.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.